Evidence map›Paper›PMID 18048707›Full record

ReviewJournal of the Royal Society of Medicine2007

Hyperglycaemia and mortality.

Khairollah Asadollahi, Nicholas Beeching, Geoffrey Gill

Abstract readReview
In one paragraph

Review in Journal of the Royal Society of Medicine, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Global burden of MDR-TB and XDR-TB attributable to high fasting plasma glucose from 1990 to 2019: a retrospective analysis based on the global burden of disease study 2019.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Blood glucose and stroke.Current treatment options in cardiovascular medicine · 2012
    Article
  10. Article
  11. The cardiovascular morbidity associated with hyperglycaemia.Journal of the Royal Society of Medicine · 2008
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Khairollah AsadollahiLiverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK.
Nicholas Beeching
Geoffrey Gill

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several studies over the last decade have linked hyperglycaemia on hospital admission with subsequent mortality risk. The evidence is strongest for patients with myocardial infarction or acute coronary syndromes, but evidence also links hyperglycaemia with mortality from stroke and other medical illnesses. The effect seems independent of a previous diagnosis of diabetes mellitus; indeed, some studies suggest that mortality may be higher in patients with hyperglycaemia and no previous diabetes diagnosis compared with known diabetic patients. The effect on outcome of therapeutically lowering blood glucose levels has been considered in a small number of studies, but so far the results are conflicting. Further work is needed, focusing on more standardized surveys--previous studies vary in their use of blood or plasma, as well as cut-off levels for hyperglycaemia--and larger intervention studies.

Indexed as

AdultBlood GlucoseCardiovascular DiseasesHospitalizationHumansHyperglycemiaRisk FactorsBlood Glucose

Identifiers

PMID18048707
PMCPMC2099401

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.